Autopsy report · NCT01447589

Radical Lung Radiotherapy Plus Nelfinavir

“failed to recruit, no suitable patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Oxford University Hospitals NHS Trust

Sponsor type

University, hospital or other

Conditions

Lung Cancer

Interventions

nelfinavir; Radical Radiotherapy

Participants

0

Sites

1

Countries

United Kingdom

Trials that died the same way

• Bone Healing in Healthy and Post-menopausal Osteoporotic Women
  “Unable to recruit suitable patients” (89% match in meaning)
• Nitropaste in Breast Reduction
  “Unable to recruit patients” (87% match in meaning)
• Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19
  “Failure of recruiting patients” (87% match in meaning)
• The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer
  “Unable to recruit sufficient patients” (86% match in meaning)
• Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
  “not able to recruit patients” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.